UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, ...

Ana Christina sits down with Dr. Daniell Miller, Chief of Thoracic Surgery, and Dr. Nikhil Patel, Associate Professor of ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

New drugs and therapies have become indispensable for treating an array of cancers. Unfortunately, they can also cause damage to the heart, a side effect that has led to the development of a new ...

Oscar-winning filmmaker Steve McQueen is revealing today that two years ago he was diagnosed with prostate cancer and ...

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

Periodontal (gum) disease and diabetes are locked in a grim partnership aimed at undermining your health, experts warn.

A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...